THE BEST SIDE OF PROTEINASE K INHIBITOR

The lack of ER, HER2, and PR expression in triple damaging breast tumors presents a significant obstacle in designing qualified therapies (Katz and Alsharedi 2017). To deal with this, several research have appeared into unique procedures which might be specific in TNBC with out a broader systemic influence (Katz and Alsharedi 2017). Gene expression